INSIGHTS ON CELL & GENE COMMERCIALIZATION ISSUES
-
How Platform Technologies Are Shaping The Gene Therapy Landscape
Leading experts in gene therapy discuss CMC strategy for platform technologies, product lifecycle management, and the role CDMOs play in moving the space forward.
-
Adapting A rcAAV Assay For Commercial Manufacturing
Better understand the intricacies of AAV triple transfection and how advances in vector production and cell line optimization are enhancing gene therapy.
-
Increasing The CGT Field's Investment In Innovation
In this segment from the Cell & Gene Live! Event Modernizing CAR-T Manufacturing: Is Point Of Care The Future?, our expert panelists respond to an audience question about how the industry can increase investment in the field’s innovation.
-
The Future Of Autologous CAR-T Manufacturing: Balancing Innovation With Improvement
Experts from last month's Cell & Gene Live event discuss the innovations seen in CAR-T manufacturing and shared their thoughts on the feasibility of decentralized and point-of-care models to address manufacturing challenges.
-
3 Strategies For Articulating A Coherent Product Value Story
These strategies are designed to help you navigate the intricate landscape of product development, ensuring that your innovation not only reaches the market but also achieves sustainable success in a competitive environment.
-
Key Takeaways And Market Insights From The Inaugural ThinkLive Summit
The inaugural ThinkLive Cell and Gene Therapy Summit explored the industry’s dynamic landscape, highlighting collaboration, communication, and market access challenges.
-
Advertising & Promotional Review Consulting
ProPharma has built the world’s leading and first full-service global solution dedicated to Advertising & Promotional Review.
-
Strategic Considerations For Success In Gene-Based Therapeutics Development
The forces that impact gene therapy development continue to evolve dramatically. This paper explores strategic considerations for regulatory, operational, and commercial success.
-
CRISPR And The Commercialization Of Gene-Based Therapies
The importance of early collaboration between drug developers, manufacturers, and payers is becoming more evident, as it aids in the creation of meaningful clinical endpoints and the formulation of a viable market access strategy.
-
Takeaways From Cencora's Inaugural Cell And Gene Therapy Summit
Collaboration, communication, and competition are key to advancing cell and gene therapy. Experts share insights from Cencora's inaugural CGT summit.